These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23914021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED.
    J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
    Yebyo HG, Zappacosta S, Aschmann HE, Haile SR, Puhan MA.
    BMC Cardiovasc Disord; 2020 Sep 17; 20(1):418. PubMed ID: 32942999
    [Abstract] [Full Text] [Related]

  • 5. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B, Altobelli KK, Williams K, Cannon CP, Pencina MJ, Sniderman AD, Thanassoulis G.
    Circulation; 2017 Nov 07; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A, Sabbah L, Perdrix L, Blanchard D, Danchin N, Puymirat E.
    Arch Cardiovasc Dis; 2013 Oct 07; 106(10):511-6. PubMed ID: 24080324
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Statin efficacy in primary CVD prevention might diminish with patient age.
    Fernández-Ruiz I.
    Nat Rev Cardiol; 2019 Apr 07; 16(4):200. PubMed ID: 30783252
    [No Abstract] [Full Text] [Related]

  • 12. Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: meta-regression of randomized placebo-controlled trials.
    Takagi H, Umemoto T, All-Literature Investigation of Cardiovascular Evidence (ALICE) Group.
    Int J Cardiol; 2013 Oct 12; 168(5):4850-3. PubMed ID: 23890857
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
    Zhao B, He X, Wu J, Yan S.
    BMC Cardiovasc Disord; 2020 Jun 10; 20(1):282. PubMed ID: 32522146
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
    Stam-Slob MC, Visseren FL, Wouter Jukema J, van der Graaf Y, Poulter NR, Gupta A, Sattar N, Macfarlane PW, Kearney PM, de Craen AJ, Trompet S.
    Clin Res Cardiol; 2017 Jan 10; 106(1):58-68. PubMed ID: 27554244
    [Abstract] [Full Text] [Related]

  • 17. Statins in the primary prevention of cardiovascular disease.
    Reiner Ž.
    Nat Rev Cardiol; 2013 Aug 10; 10(8):453-64. PubMed ID: 23736519
    [Abstract] [Full Text] [Related]

  • 18. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N, Henrard S, van den Akker M, Goderis G, Buntinx F, Van Pottelbergh G, Vaes B.
    BMC Cardiovasc Disord; 2018 Nov 06; 18(1):209. PubMed ID: 30400778
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD, Brown T, Lee JY, Shah S, Henley E, Long T, Luther S, Lloyd-Jones DM, Jean-Jacques M, Kandula NR, Sanchez T, Baker DW.
    Circ Cardiovasc Qual Outcomes; 2015 Nov 06; 8(6):560-6. PubMed ID: 26555123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.